
Bennett M. Celsa
Supervisory Patent Examiner (ID: 14197, Phone: (571)272-0807 , Office: P/1600 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1600, 1621, 1627, 3991, 1654, 1811, 1618, 1639 |
| Total Applications | 690 |
| Issued Applications | 420 |
| Pending Applications | 112 |
| Abandoned Applications | 158 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 09/445816 | CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER | Dec 12, 1999 | Abandoned |
Array
(
[id] => 1314464
[patent_doc_number] => 06610824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-26
[patent_title] => 'Amylin agonist peptides and uses therefor'
[patent_app_type] => B2
[patent_app_number] => 09/454533
[patent_app_country] => US
[patent_app_date] => 1999-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10988
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610824.pdf
[firstpage_image] =>[orig_patent_app_number] => 09454533
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/454533 | Amylin agonist peptides and uses therefor | Dec 5, 1999 | Issued |
| 09/453122 | THERMO-CHEMICAL SENSORS AND USES THEREOF | Dec 1, 1999 | Abandoned |
Array
(
[id] => 1359837
[patent_doc_number] => 06573239
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-03
[patent_title] => 'Apolipoprotein A-I agonist compounds'
[patent_app_type] => B1
[patent_app_number] => 09/453841
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 59258
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 512
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/573/06573239.pdf
[firstpage_image] =>[orig_patent_app_number] => 09453841
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453841 | Apolipoprotein A-I agonist compounds | Nov 30, 1999 | Issued |
Array
(
[id] => 1291471
[patent_doc_number] => 06630450
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-07
[patent_title] => 'Method of treating dyslipidemia'
[patent_app_type] => B1
[patent_app_number] => 09/453826
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 11
[patent_no_of_words] => 59247
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 665
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/630/06630450.pdf
[firstpage_image] =>[orig_patent_app_number] => 09453826
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453826 | Method of treating dyslipidemia | Nov 30, 1999 | Issued |
Array
(
[id] => 1169535
[patent_doc_number] => 06753313
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'Multimeric Apoa-I agonist compounds'
[patent_app_type] => B1
[patent_app_number] => 09/453834
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 59260
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 669
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753313.pdf
[firstpage_image] =>[orig_patent_app_number] => 09453834
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453834 | Multimeric Apoa-I agonist compounds | Nov 30, 1999 | Issued |
Array
(
[id] => 4326198
[patent_doc_number] => 06329341
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Method of treating septic shock'
[patent_app_type] => 1
[patent_app_number] => 9/453605
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 11
[patent_no_of_words] => 60024
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 680
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329341.pdf
[firstpage_image] =>[orig_patent_app_number] => 453605
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453605 | Method of treating septic shock | Nov 30, 1999 | Issued |
Array
(
[id] => 1205869
[patent_doc_number] => 06716816
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-06
[patent_title] => 'Multimeric Apo A-I agonist compounds'
[patent_app_type] => B1
[patent_app_number] => 09/453840
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 59312
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 740
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/716/06716816.pdf
[firstpage_image] =>[orig_patent_app_number] => 09453840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453840 | Multimeric Apo A-I agonist compounds | Nov 30, 1999 | Issued |
Array
(
[id] => 1325064
[patent_doc_number] => 06602854
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Branched multimeric Apo A-I agonist compounds'
[patent_app_type] => B1
[patent_app_number] => 09/453833
[patent_app_country] => US
[patent_app_date] => 1999-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 30
[patent_no_of_words] => 59253
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 698
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602854.pdf
[firstpage_image] =>[orig_patent_app_number] => 09453833
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/453833 | Branched multimeric Apo A-I agonist compounds | Nov 30, 1999 | Issued |
| 09/214348 | ELECTROCHEMICAL SOLID PHASE SYNTHESIS OF POLYMERS | Nov 22, 1999 | Abandoned |
Array
(
[id] => 1037388
[patent_doc_number] => 06872536
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-29
[patent_title] => 'Chemotactic peptide antagonists for imaging sites of inflammation'
[patent_app_type] => utility
[patent_app_number] => 09/437701
[patent_app_country] => US
[patent_app_date] => 1999-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 12864
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872536.pdf
[firstpage_image] =>[orig_patent_app_number] => 09437701
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/437701 | Chemotactic peptide antagonists for imaging sites of inflammation | Nov 9, 1999 | Issued |
Array
(
[id] => 4407308
[patent_doc_number] => 06309859
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Method for removing N-terminal methionine'
[patent_app_type] => 1
[patent_app_number] => 9/436518
[patent_app_country] => US
[patent_app_date] => 1999-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 30232
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/309/06309859.pdf
[firstpage_image] =>[orig_patent_app_number] => 436518
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/436518 | Method for removing N-terminal methionine | Nov 8, 1999 | Issued |
Array
(
[id] => 1462768
[patent_doc_number] => 06350731
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-02-26
[patent_title] => 'Platelet-derived growth factor analogues'
[patent_app_type] => B1
[patent_app_number] => 09/432879
[patent_app_country] => US
[patent_app_date] => 1999-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 5753
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/350/06350731.pdf
[firstpage_image] =>[orig_patent_app_number] => 09432879
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/432879 | Platelet-derived growth factor analogues | Nov 1, 1999 | Issued |
Array
(
[id] => 7620035
[patent_doc_number] => 06943148
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-09-13
[patent_title] => 'Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity'
[patent_app_type] => utility
[patent_app_number] => 09/430735
[patent_app_country] => US
[patent_app_date] => 1999-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 13188
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/943/06943148.pdf
[firstpage_image] =>[orig_patent_app_number] => 09430735
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/430735 | Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity | Oct 28, 1999 | Issued |
Array
(
[id] => 1239369
[patent_doc_number] => 06686164
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-02-03
[patent_title] => 'Low allergenic protein variants'
[patent_app_type] => B1
[patent_app_number] => 09/417608
[patent_app_country] => US
[patent_app_date] => 1999-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 19566
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/686/06686164.pdf
[firstpage_image] =>[orig_patent_app_number] => 09417608
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/417608 | Low allergenic protein variants | Oct 12, 1999 | Issued |
Array
(
[id] => 4260569
[patent_doc_number] => 06258779
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-10
[patent_title] => 'Method of using fetuin to induce apoptosis in cancer cells'
[patent_app_type] => 1
[patent_app_number] => 9/414136
[patent_app_country] => US
[patent_app_date] => 1999-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8409
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/258/06258779.pdf
[firstpage_image] =>[orig_patent_app_number] => 414136
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/414136 | Method of using fetuin to induce apoptosis in cancer cells | Oct 6, 1999 | Issued |
Array
(
[id] => 1570000
[patent_doc_number] => 06498005
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Homogeneous assay methods'
[patent_app_type] => B1
[patent_app_number] => 09/408884
[patent_app_country] => US
[patent_app_date] => 1999-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5952
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498005.pdf
[firstpage_image] =>[orig_patent_app_number] => 09408884
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/408884 | Homogeneous assay methods | Sep 28, 1999 | Issued |
Array
(
[id] => 6876863
[patent_doc_number] => 20010007016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-07-05
[patent_title] => 'PEPTIDE DERIVATIVES'
[patent_app_type] => new-utility
[patent_app_number] => 09/406822
[patent_app_country] => US
[patent_app_date] => 1999-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7961
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20010007016.pdf
[firstpage_image] =>[orig_patent_app_number] => 09406822
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/406822 | PEPTIDE DERIVATIVES | Sep 27, 1999 | Abandoned |
Array
(
[id] => 1133383
[patent_doc_number] => 06783947
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-31
[patent_title] => 'Protecting groups for biological labeling'
[patent_app_type] => B1
[patent_app_number] => 09/393579
[patent_app_country] => US
[patent_app_date] => 1999-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19251
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/783/06783947.pdf
[firstpage_image] =>[orig_patent_app_number] => 09393579
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/393579 | Protecting groups for biological labeling | Sep 8, 1999 | Issued |
Array
(
[id] => 4317270
[patent_doc_number] => 06248540
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => 'Combinatorial synthesis and analysis of organometallic compounds and homogeneous catalysts'
[patent_app_type] => 1
[patent_app_number] => 9/390001
[patent_app_country] => US
[patent_app_date] => 1999-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 34
[patent_no_of_words] => 27345
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248540.pdf
[firstpage_image] =>[orig_patent_app_number] => 390001
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/390001 | Combinatorial synthesis and analysis of organometallic compounds and homogeneous catalysts | Sep 2, 1999 | Issued |